T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QVCGA
2276
DELISTED
QVC Group Inc Series A
QVCGA
| $371K | ﹤0.01% |
4,557
+120
| +3% | +$12.2K |
|
|
CTEV
2277
Claritev Corp
CTEV
$716M
| $371K | ﹤0.01% |
8,062
-10,533
| -57% | -$841K |
|
2278
Rio Tinto
RIO
$160B
| $370K | ﹤0.01% |
5,200
-1,604
| -24% | -$101K |
|
2279
C3.ai
AI
$1.58B
| $369K | ﹤0.01% |
32,994
-7,100
| -18% | -$88.9K |
|
2280
Shutterstock
SSTK
$217M
| $369K | ﹤0.01% |
6,994
+279
| +4% | +$14.2K |
|
2281
G-III Apparel Group
GIII
$1.43B
| $368K | ﹤0.01% |
26,832
+753
| +3% | +$12.7K |
|
2282
Banc of California
BANC
$3.11B
| $367K | ﹤0.01% |
23,021
+829
| +4% | +$13.5K |
|
2283
BlueLinx
BXC
$705M
| $366K | ﹤0.01% |
5,150
-311
| -6% | -$21.2K |
|
|
CWEN.A
2284
DELISTED
Clearway Energy Class A
CWEN.A
| $366K | ﹤0.01% |
12,218
+1,942
| +19% | +$60.6K |
|
2285
Vanguard Morningstar Total Stock Market ETF
VTI
$696B
| $366K | ﹤0.01% |
1,915
+415
| +28% | +$80K |
|
|
RTL
2286
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $366K | ﹤0.01% |
61,681
-4,366
| -7% | -$27.8K |
|
2287
Universal Electronics
UEIC
$66.6M
| $365K | ﹤0.01% |
17,526
+1,700
| +11% | +$35.3K |
|
2288
AbCellera Biologics
ABCL
$3.36B
| $364K | ﹤0.01% |
35,963
+2,249
| +7% | +$26K |
|
2289
GoPro
GPRO
$117M
| $364K | ﹤0.01% |
73,178
+1,957
| +3% | +$10.3K |
|
2290
National Presto Industries
NPK
$987M
| $363K | ﹤0.01% |
+5,298
| New | +$362K |
|
|
LUMO
2291
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $361K | ﹤0.01% |
100,000
-12,576
| -11% | -$82.3K |
|
2292
NRC Health Common Stock
NRC
$471M
| $360K | ﹤0.01% |
9,656
+231
| +2% | +$8.94K |
|
2293
Artivion
AORT
$1.39B
| $359K | ﹤0.01% |
29,651
-3,666
| -11% | -$44K |
|
|
DM
2294
DELISTED
Desktop Metal, Inc.
DM
| $359K | ﹤0.01% |
26,392
-61
| -0.2% | -$1.27K |
|
2295
Peapack-Gladstone Financial
PGC
$822M
| $358K | ﹤0.01% |
9,611
+351
| +4% | +$13.4K |
|
|
WSR
2296
DELISTED
Whitestone REIT
WSR
| $358K | ﹤0.01% |
37,135
-12,205
| -25% | -$112K |
|
|
RDUS
2297
DELISTED
Radius Recycling
RDUS
| $357K | ﹤0.01% |
11,654
+1,208
| +12% | +$37.3K |
|
2298
Barrett Business Services
BBSI
$800M
| $356K | ﹤0.01% |
15,252
+380
| +3% | +$8.61K |
|
2299
BioXcel Therapeutics
BTAI
$34.9M
| $356K | ﹤0.01% |
1,036
+11
| +1% | +$2.66K |
|
2300
Canterbury Park Holding Corp
CPHC
$81.4M
| $356K | ﹤0.01% |
11,379
-1,100
| -9% | -$28.3K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.